Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For CCRO3.SA
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 13.35 1.47 1.30
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 24.37 14.76 11.87
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.10 6.37 6.18
Cash 12.24 3.99 3.56
Capex 37.02 -0.55 -0.87
Free Cash Flow -91.54 -0.12 1.38
Revenue -24.46 2.33 3.08
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -4.35 0.40 0.42
Operating Margin 2.25 0.29 0.29
ROA -41.62 < 0.005 < 0.005
ROE -40.28 0.03 0.04
ROIC -45.75 0.01 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of CCRO3.SA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of CCRO3.SA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of CCRO3.SA is permitted for members.